Rituximab for IgG4-related disease: a prospective, open-label trial
Rituximab for IgG4-related disease: a prospective, open-label trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab for IgG4-related disease: a prospective, open-label trial have?
Rituximab for IgG4-related disease: a prospective, open-label trial has 714 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab for IgG4-related disease: a prospective, open-label trial published?
Rituximab for IgG4-related disease: a prospective, open-label trial has 2015 year in the ScholarIQ index.
What is the open-access status of Rituximab for IgG4-related disease: a prospective, open-label trial?
Rituximab for IgG4-related disease: a prospective, open-label trial has closed oa status in the ScholarIQ index.
What is the DOI of Rituximab for IgG4-related disease: a prospective, open-label trial?
The DOI for Rituximab for IgG4-related disease: a prospective, open-label trial is on the source record.
What is the PMID of Rituximab for IgG4-related disease: a prospective, open-label trial?
The PMID for Rituximab for IgG4-related disease: a prospective, open-label trial is on the source record.
What is the OpenAlex record for Rituximab for IgG4-related disease: a prospective, open-label trial?
The OpenAlex for Rituximab for IgG4-related disease: a prospective, open-label trial is on the source record.